최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기기본간호학회지 = Journal of Korean Academy of Fundamentals of Nursing, v.20 no.2, 2013년, pp.147 - 156
신용순 (국립창원대학교) , 이정아 (삼성서울병원 신경외과) , 배소현 (분당 서울대병원 신경외과) , 이수연 (서울성모병원 뇌종양) , 장민경 (연세대 세브란스병원 뇌종양센터)
Purpose: The study was done to define complementary and alternative medicine (CAM) use among primary brain tumor patients and factors influencing use. Methods: The study was conducted with convenience sampling in 5 neuro-oncology centers in Seoul and Gyeonggi Province. Data were collected using a 25...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
보완대체요법이란 무엇인가? | 보완대체요법이란 기존의 정통 의학으로 인정되지 않는 다양한 건강관리 실무와 시스템, 생산물 등을 지칭한다(National Center of Complementary and Alternative Medicine [NCCAM], 2012). 세계적인 조사연구에 의하면 보완대체요법은 암환자 사이에서 매우 대중적으로 이용되고 있다. | |
암환자의 보완대체요법 이용에 영향을 미치는 요인은 어떻게 분류할 수 있나? | 선행 연구들이 보고하는 암환자의 보완대체요법 이용에 영향을 미치는 요인은 크게 인구사회학적 요인과 질환 관련 요인, 치료 관련 요인 등으로 분류할 수 있다. 인구사회학적 측면에서는 나이와 성별, 교육수준, 경제수준, 결혼 여부 등이, 질환 관련 측면에서는 기능상태 등이, 치료 관련 측면에서는 호르몬 치료 등이 보완대체요법 사용에 영향을 미친다고 알려져 왔다(Bell, 2010; Moran et al. | |
보완대체요법 이용에 영향을 미치는 요인 중 인구사회학적 측면에는 무엇이 있나? | 선행 연구들이 보고하는 암환자의 보완대체요법 이용에 영향을 미치는 요인은 크게 인구사회학적 요인과 질환 관련 요인, 치료 관련 요인 등으로 분류할 수 있다. 인구사회학적 측면에서는 나이와 성별, 교육수준, 경제수준, 결혼 여부 등이, 질환 관련 측면에서는 기능상태 등이, 치료 관련 측면에서는 호르몬 치료 등이 보완대체요법 사용에 영향을 미친다고 알려져 왔다(Bell, 2010; Moran et al., 2013; Verhoef et al. |
Armstrong, T., Cohen, M. Z., Hess, K. R., Manning, R., Lee, E. L., Tamayo, G., et al. (2006). Complementary and alternative medicine use and quality of life in patients with primary brain tumors. Journal of Pain and Symptom Management, 32, 148-154.
Arthur, K., Belliard, J. C., Hardin, S. B., Knecht, K., Chen, C. S., & Montgomery, S. (2012). Practices, attitudes, and beliefs associated with complementary and alternative medicine (CAM) use among cancer patients. Integrative Cancer Therapies, 11, 232-242. http://dx.doi.org/10.1177/1534735411433832
Bairati, I., Meyer, F., Gelinas, M., Fortin, A., Nabid, A., Brochet, F., et al. (2005). Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. Journal of Clinical Oncology, 23, 5805-5813.
Bell, R. M. (2010). A review of complementary and alternative medicine practices among cancer survivors. Clinical Journal of Oncology Nursing, 14, 365-370.
Brown, P. D., Ballman, K. V., Rummans, T. A., Maurer, M. J., Sloan, J. A., Boeve, B. F., et al. (2006). Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. Journal of Neuro-Oncology, 76, 283-291. http://dx.doi.org/10.1007/s11060-005-7020-9
Chun, S. I. (2004). Complementary alternative medicine. Seoul: Gyechuk Publishing Company.
Dolecek, T. A., Propp, J. M., Stroup, N. E., & Kruchko, C. (2012). CBTRUS Statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-Oncology, 14, v1-v49. http://dx.doi.org/10.1093/neuonc/nos218
Ferreira, P. R., Fleck, J. F., Diehl, A., Barletta, D., Braga-Filho, A., Barletta, A., et al. (2004). Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial. Head and Neck, 26, 313-321.
Fox, S., Laws, E. R., Anderson F., & Farace, E. (2006). Complementary therapy use and quality of life in persons with high-grade gliomas. Journal of Neuroscience Nursing, 38, 212-220.
Heese, O., Schmidt, M., Nickel, S., Berger, H., Goldbrunner, R., Tonn, J. C., et al. (2010). Complementary therapy use in patients with glioma: An observational study. Neurology, 75, 2229-2235. http://dx.doi.org/10.1212/WNL.0b013e31820202c6
Horneber, M., Bueschel, G., Dennert, G., Less, D., Ritter, E., & Zwahlen, M. (2012). How many cancer patients use complementary and alternative medicine: A systematic review and metaanalysis. Integrative Cancer Therapies, 11, 187-203. http://dx.doi.org/10.1177/1534735411423920
Kang, E., Yang, E. J., Kim, S. M., Chung, I. Y., Han, S. A., Ku, D. H., et al. (2012). Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: A descriptive study. Supportive Care in Cancer, 20, 461-473. http://dx.doi.org/10.1007/s00520-011-1094-z
Karnofsky, D., & Burchenal, J. (1949). The clinical evaluation of chemotherapeutic agents in cancer. In MacLeod CM (Ed.), Evaluation of chemotherapeutic agents (pp. 196): Columbia Univ Press.
Kim, D. Y., Kim, B. S., Lee, K. H., Lee, M. A., Hong, Y. S., Shin, S. W., et al. (2008). Discrepant views of Korean medical oncologists and cancer patients on complementary and alternative medicine. Cancer Research and Treatment, 40, 87-92. http://dx.doi.org/10.4143/crt.2008.40.2.87
Kim, M. J., Lee, S. D., Kim, D. R., Kong, Y. H., Sohn, W. S., Ki, S. S., et al. (2004). Use of complementary and alternative medicine among Korean cancer patients. Korean Journal of Internal Medicine, 19, 250-256.
Ku, C. F., & Koo, M. (2012). Association of distress symptoms and use of complementary medicine among patients with cancer. Journal of Clinical Nursing, 21, 736-744. http://dx.doi.org/10.1111/j.1365-2702.2011.03884.x
Lawenda, B. D., Kelly, K. M., Ladas, E. J., Sagar, S. M., Vickers, A., & Blumberg, J. B. (2008). Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? Journal of the National Cancer Institute, 100, 773-783.
McDermott, C. L., Blough, D. K., Fedorenko, C. R., Arora, N. K., Zeliadt, S. B., Fairweather, M. E., et al. (2012). Complementary and alternative medicine use among newly diagnosed prostate cancer patients. Supportive Care in Cancer, 20, 65-73. http://dx.doi.org/10.1007/s00520-010-1055-y
Moran, M. S., Ma, S., Jagsi, R., Yang, T. I., Higgins, S. A., Weidhaas, J. B., et al. (2013). A prospective, multicenter study of complementary/ alternative medicine (CAM) utilization during definitive radiation for breast cancer. International Journal of Radiation Oncology, Biology, Physics, 85, 40-46. http://dx.doi.org/10.1016/j.ijrobp.2012.03.025
Nandy, K. (2012). Understanding and quantifying: Effect sizes. Retrieved February 14, 2013, from School of Nursing, University of California San Francisco Web site: http://nursing.ucla.edu/workfiles/research/Effect%20Size%204-9-2012.pdf
National Center of Complementary and Alternative Medicine (2012). What is complementary and alternative medicine? Retrieved February 14, 2013, from the National Center of Complementary and Alternative Medicine Web site: http://nccam.nih.gov/health/whatiscam
Posadzki, P., Watson, L., & Ernst, E. (2013). Herb-drug interactions: An overview of systematic reviews. British Journal of Clinical Pharmacology, 75, 603-618. http://dx. doi.org/10.1111/j.1365-2125.2012.04350.x
Seo, H. S., Yang, K. S., Kim, N. Y., Kim, H. Y., & Kim, M. K. (2009). SPSS Regression analysis (3ed.). Seoul: Hannare Academy.
Shih, V., Chiang, J. Y., & Chan, A. (2009). Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients. Annals of Oncology, 20, 752-757. http://dx.doi.org/10.1093/annonc/mdn659
Verhoef, M. J., Hagen, N., Pelletier, G., & Forsyth, P. (1999). Alternative therapy use in neurologic diseases: Use in brain tumor patients. Neurology, 52, 617-622.
Wanchai, A., Armer, J. M., & Stewart, B. R. (2010). Complementary and alternative medicine use among women with breast cancer: A systematic review. Clinical Journal of Oncology Nursing, 14, E45-55. http://dx.doi.org/10.1188/10.CJON.E45-E55
Yun, Y. H., Lee, M. K., Park, S. M., Kim, Y. A., Lee, W. J., Lee, K. S., et al. (2013). Effect of complementary and alternative medicine on the survival and health-related quality of life among terminally ill cancer patients: A prospective cohort study. Annals of Oncology, 24, 489-494. http://dx.doi.org/10.1093/annonc/mds469
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.